Yazar "de la Rosette, Jean J. M. C. H." için Diğer Yayınlar Koleksiyonu listeleme
-
Definition, treatment and outcome of residual fragments in staghorn stones
Ermiş, Osman; Somani, Bhaskar; Reeves, Thomas; Güven, Selçuk; Pes, Pilar Laguna; Chawla, Arun; Hegde, Padmaraj; de la Rosette, Jean J. M. C. H. (Elsevier Singapore Pte Ltd., 2020)Technological advances in minimally invasive treatment of stone disease and its integration with concomitant clinical practice are amongst the most important achievements in urology. Despite the wealth of information ... -
Mobile health in urology: The good, the bad and the ugly
Azevedo, Nuno Pereira; Gravas, Stavros; de la Rosette, Jean J. M. C. H. (MDPI, 2020)Our aim is to present the current position of mobile health (mHealth) and the delivery of healthcare services via mobile communication devices in urology. We conducted a literature review of urology mHealth papers on PubMed. ... -
Overview of current pharmacotherapeutic options in benign prostatic hyperplasia
Koudonas, Antonios; Anastasiadis, Anastasios; Tsiakaras, Stavros; Langas, Georgios; Savvides, Eliophotos; Mykoniatis, Ioannis; Memmos, Dimitrios; Baniotis, Panagiotis; Vakalopoulos, Ioannis; de la Rosette, Jean J. M. C. H.; Dimitriadis, Georgios (Taylor and Francis Ltd., 2023)Introduction: Benign prostatic hyperplasia (BPH) represents the histological entity of prostate cell proliferation, which inflicts a gradually increasing obstruction of the bladder outlet and is accompanied by a progressing ... -
Primary whole-gland ablation for the treatment of clinically localized prostate cancer: A focal therapy society best practice statement
Deivasigamani, Sriram; Kotamarti, Srinath; Rastinehad, Ardeshir R.; Salas, Rafael Sanchez; de la Rosette, Jean J. M. C. H.; Lepor, Herbert; Pinto, Peter; Polascik, Thomas J. (Elsevier, 2023)Context: Whole-gland ablation is a feasible and effective minimally invasive treatment for localized prostate cancer (PCa). Previous systematic reviews supported evidence for favorable functional outcomes, but oncological ...